Sofosbuvir: A Potential Treatment for Ebola

被引：1
|
作者：
Reznik, Sandra E. [1 ,2 ,3 ,4 ]
Tiwari, Amit K. [5 ]
Ashby, Charles R., Jr. [1 ]
机构：
[1] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY 11439 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Womens Hlth, Bronx, NY 10467 USA
[5] Univ Toledo, Dept Pharmacol & Expt Therapeut, Coll Pharm & Pharmaceut Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
FRONTIERS IN PHARMACOLOGY | 2018年 / 9卷
关键词：
Ebola; sofosbuvir; RNA virus; RNA dependent RNA polymerase; triphosphate metabolite; HEPATITIS-C VIRUS; DISEASE; INFECTION; RNA; FAVIPIRAVIR; POLYMERASE; ANTIVIRALS; GS-5734; PATIENT;
D O I：
10.3389/fphar.2018.01139
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients
    Tseng, Alice
    Wong, David K.
    JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 651 - 653
  • [42] Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens
    Maasoumy, Benjamin
    Vermehren, Johannes
    Welker, Martin-Walter
    Bremer, Birgit
    Perner, Dany
    zu Siederdissen, Christoph Hoener
    Deterding, Katja
    Lehmann, Patrick
    Cloherty, Gavin
    Reinhardt, Birgit
    Pawlotsky, Jean-Michel
    Manns, Michael P.
    Zeuzem, Stefan
    Cornberg, Markus
    Wedemeyer, Heiner
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 473 - 482
  • [43] Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naive patients: Findings from two randomized trials
    Tam, Edward
    Luetkemeyer, Anne F.
    Mantry, Parvez S.
    Satapathy, Sanjaya K.
    Ghali, Peter
    Kang, Minhee
    Haubrich, Richard
    Shen, Xianlin
    Ni, Liyun
    Camus, Gregory
    Copans, Amanda
    Rossaro, Lorenzo
    Guyer, Bill
    Brown, Robert S., Jr.
    LIVER INTERNATIONAL, 2018, 38 (06) : 1010 - 1021
  • [44] Sofosbuvir for treatment of chronic hepatitis C
    Kattakuzhy, Sarah
    Levy, Rachel
    Kottilil, Shyam
    HEPATOLOGY INTERNATIONAL, 2015, 9 (02) : 161 - 173
  • [45] Sofosbuvir and velpatasvir for the treatment of hepatitis C
    Jackson, Whitney E.
    Everson, Gregory T.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (06) : 501 - 505
  • [46] Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant
    Pinana, J. L.
    Serra, M. A.
    Hernandez-Boluda, J. C.
    Navarro, D.
    Calabuig, M.
    Solano, C.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (01) : 89 - 92
  • [47] Geographic charisma and the potential energy of Ebola
    Herrick, Clare
    SOCIOLOGY OF HEALTH & ILLNESS, 2019, 41 (08) : 1488 - 1502
  • [48] Sofosbuvir in the Treatment of Chronic Hepatitis C: New Dog, New Tricks
    Abraham, George M.
    Spooner, Linda M.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (03) : 411 - 415
  • [49] Validated Spectrodensitometric Method for Simultaneous Estimation of Sofosbuvir, Ribavirin and Saxagliptin in their Pure and Pharmaceutical Dosage Forms
    El-Shaboury, Salwa R.
    El-Gizawy, Samia M.
    Atia, Noha N.
    Abo-Zeid, Mohammad Nabil
    CURRENT PHARMACEUTICAL ANALYSIS, 2018, 14 (03) : 212 - 218
  • [50] An evaluation of ledipasvir plus sofosbuvir for the treatment of chronic hepatitis C infection
    Balatow, Pearson
    Sandlin, Amber
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (14) : 1839 - 1846
12345